Blood tests often show a high white blood cell or lymphocyte level. You’d get more tests to find out if this is leukemia. Two other types of leukemia -- acute myeloid leukemia (AML) and chronic ...

Medically reviewed by Gagandeep Brar, MD Leukemias and lymphomas are often grouped together because they are both blood-related cancers that originate in lymphocytes. However, leukemia originates in ...

Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have ...

The TREM2 receptor may hold the keys to understanding how myeloid cells affect immune responses to neurological disorders and cancer. Triggering receptors expressed on myeloid cells (TREMs) are a cell ...

Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

Vδ1+ γδ T cells are tissue-resident lymphocytes that exert a unique and ... including acute myeloid leukemia, myelodysplastic syndrome, acute lymphoblastic leukemia, and others.

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

This lysis is the definitive goal of an immune therapy for AML by using a defined T-cell epitope peptide derived from a LAA. AML: Acute myeloid leukemia; CTL: Cytotoxic T lymphocyte; FasL ...